PA3-813

antibody from Invitrogen Antibodies

Targeting: RARG NR1B3, RARC

Western blot (Data presented on provider website)

Immunoprecipitation (Recommended by provider)

Gel shift (Recommended by provider)

Antibody Data

Product number

PA3-813

Provider

Invitrogen Antibodies

Product name

RAR gamma-1 Polyclonal Antibody

Antibody type

Polyclonal

Antigen

Synthetic peptide

Description

PA3-813 detects recombinant human retinoic acid receptor (RAR) gamma-1. The immunizing sequence is 100% conserved in mouse. This antibody detects RAR gamma-1, but not RAR gamma-2, or either of the alpha or beta forms of RAR. PA3-813 has been successfully used in Western blot, immunoprecipitation and gel shift procedures. By Western blot, this antibody detects an ~50 kDa protein representing RAR gamma-1 from transiently transfected 293T cells. PA3-813 has been shown to efficiently super shift the human RAR gamma-1/retinoid X receptor (RXR)/RAR response element complex in gel super shift experiments using a number of different response elements. PA3-813 immunizing peptide corresponds to the N-terminus of RAR gamma-1. This peptide (Cat. # PEP-228) is available for use in neutralization and control experiments.

Reactivity

Human, Mouse, Rat

Host

Rabbit

Isotype

IgG

Vial size

100 µL

Concentration

Conc. Not Determined

Storage

-20° C, Avoid Freeze/Thaw Cycles

References

Submitted references

Pharmacologic retinoid signaling and physiologic retinoic acid receptor signaling inhibit basal cell carcinoma tumorigenesis.

So PL, Fujimoto MA, Epstein EH Jr
Molecular cancer therapeutics 2008 May;7(5):1275-84

---

The expression of retinoic acid receptor alpha is increased in the granule cells of the dentate gyrus in schizophrenia.

Rioux L, Arnold SE
Psychiatry research 2005 Jan 30;133(1):13-21